Is HBOT the Most Underrated Anti-Ageing Tool Available Right Now?
Is HBOT the By OxyPlus — Newcastle's Specialist Hyperbaric Oxygen Therapy Clinic oxyplus.co.uk | Updated April 2026 | 9 min read
The anti-ageing industry is vast, loud, and largely ineffective. Supplements with impressive names and modest evidence. Skincare routines that cost more than a mortgage payment. Fasting protocols that require the discipline of a monk. Experimental drugs that may extend the lifespan of a mouse.
Meanwhile, something with peer-reviewed human trial evidence for reversing telomere shortening, clearing senescent cells, rebuilding skin collagen, improving cerebral blood flow, and eliminating systemic inflammation sits largely outside the mainstream conversation.
Despite evidence supporting its efficacy in modulating biological ageing markers such as telomere length and cellular senescence, HBOT remains underrepresented in longevity medicine discourse.
This post makes the case - based on published research, specific numbers, and honest caveats - that hyperbaric oxygen therapy is the most credible, most evidence-backed, and most overlooked anti-ageing tool currently available to people who aren't spending $2 million a year on their health.
At OxyPlus, our HBOT clinic in Newcastle, we think this evidence deserves to reach a wider audience. Here it is.
First: What Does "Anti-Ageing" Actually Mean?
Before making any case for a specific intervention, the term needs to be defined. "Anti-ageing" in the wellness marketing sense means almost nothing, it is applied to face creams, supplements, and IV drips with equal abandon.
In the scientific sense, anti-ageing means something specific: intervening in the biological hallmarks of ageing - the cellular and molecular mechanisms that drive the progressive loss of function across every system in the body.
In 2013, a landmark paper in Cell identified nine hallmarks of ageing. These were expanded in 2023 to twelve, and now include:
Researchers have collectively identified hallmarks of ageing including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis. Strategies to manipulate these hallmarks present opportunities for slowing, preventing, or reversing age-related diseases, thereby promoting longevity.
An intervention is genuinely anti-ageing to the degree it addresses these mechanisms - not in mice or cell cultures, but in humans, with measurable outcomes. That is the standard we are applying to HBOT.
What HBOT Does to the Hallmarks of Ageing
By intermittently elevating tissue oxygen tensions, HBOT can provoke adaptive responses that counter functional decline (supporting vascular integrity, metabolic flexibility, neuroplasticity, and immune homeostasis) while targeting hallmarks of ageing such as mitochondrial dysfunction, chronic inflammation, impaired stem-cell niches, and genomic instability.
Let us go through each one with the specific evidence.
Hallmark 1: Telomere Attrition
Telomere shortening is perhaps the most widely recognised cellular marker of biological ageing. Every time a cell divides, its telomeres shorten. When they become critically short, cells either die or enter senescence. Measuring telomere length gives a rough proxy for biological age.
Most lifestyle interventions - endurance exercise, caloric restriction, certain supplements - show effects of around 2–5% on telomere length.
The landmark Israeli clinical trial published in the journal Aging found that a 60-session HBOT protocol produced telomere length increases of over 20% in multiple immune cell populations in adults aged 64 and older. This groundbreaking study showed that HBOT can induce significant enhancements - the first human study to demonstrate telomere elongation of this magnitude through any non-pharmacological intervention.
Bryan Johnson's self-experiment, conducted with the same protocol parameters, documented a 2.6% increase in telomere length after 60 sessions - a figure that sounds modest but sits at the high end of what any intervention currently achieves in practice. He described HBOT as one of the highest-value health interventions he has undertaken.
Nothing else in the non-pharmacological longevity toolkit has demonstrated comparable telomere effects in peer-reviewed human trials.
Hallmark 2: Cellular Senescence
Senescent cells - the so-called "zombie cells" that accumulate with age, refuse to die, and secrete inflammatory signals that damage surrounding tissue - are one of the hottest targets in longevity pharmacology. Drugs like dasatinib and quercetin are being studied specifically for their senolytic effects. Topical rapamycin applied to human skin for 8 months reduced markers of skin senescence, as measured by p16INK4A protein levels.
HBOT achieved comparable senolytic results systemically, in a human trial, without a drug.
The Israeli telomere trial found that HBOT decreased the concentration of senescent cells in the blood by 10–37% across different immune cell populations. A separate prospective clinical trial found that HBOT produced a significant decrease in tissue senescent cells (p=0.03, effect size=0.84) post-HBOT in skin biopsies from adults in a healthy ageing population - confirmed through direct histological measurement, not a blood proxy.
HBOT interferes with the detrimental effects of cellular senescence, manifested by cell cycle re-entry and attenuation of senescence markers such as p16/p21/p53, SA-β-gal, lipofuscin and the SASP. HBOT also plays a role in inhibiting telomere shortening, one of the major stimuli of cellular senescence.
The senescence-associated secretory phenotype (SASP) - the inflammatory cocktail that senescent cells release into surrounding tissue - is one of the primary drivers of "inflammageing." By clearing the cells producing it, HBOT reduces this source of chronic inflammation at its origin.
Hallmark 3: Mitochondrial Dysfunction
Mitochondrial dysfunction is a hallmark of ageing. It contributes to fatigue, muscle weakness, metabolic inefficiency, and reduced cognitive performance. Hyperbaric Oxygen Therapy supports mitochondrial health by increasing oxygen availability, which improves ATP production and supports mitochondrial repair.
HBOT stimulates mitochondrial biogenesis through PGC-1α and SIRT1 - the same pathways activated by aerobic exercise and caloric restriction. More mitochondria, better-functioning mitochondria, and increased cellular energy production are the direct results. For a full discussion of the mechanisms, see our blog on HBOT and Mitochondrial Function.
This is not a marginal effect. The eight-fold increase in circulating stem cell markers documented after 20 HBOT sessions reflects, in part, the mobilisation of cells whose function depends on restored mitochondrial capacity.
Hallmark 4: Chronic Inflammation (Inflammageing)
Chronic low-grade systemic inflammation - "inflammageing" - is now understood as one of the central drivers of age-related disease across virtually every system. It accelerates cardiovascular disease, neurodegeneration, metabolic dysfunction, and cancer risk.
Bryan Johnson's most dramatic HBOT result was not the telomere extension or the stem cell figures. It was this: after 60 sessions, his hsCRP (high-sensitivity C-reactive protein, the standard marker for systemic inflammation) dropped to below detectable levels. All measurable systemic inflammation was eliminated.
The clinical mechanism is well understood. HBOT suppresses NF-κB - the master inflammatory signalling switch - reduces pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, and modulates immune cell function to break the chronic inflammatory cycle. For the full mechanistic detail, see our post on How HBOT May Reduce Inflammation.
Hallmark 5: Impaired Stem Cell Activity
HBOT increases the number of circulating stem cells by stimulating stem cell mobilisation, and changes stem cell properties by promoting proliferation and differentiation.
The eight-fold increase in circulating CD34+ stem cell markers documented at the 20-session threshold is one of the more striking quantitative findings in the HBOT literature. Stem cell exhaustion is a primary hallmark of ageing - as the body's regenerative reserve depletes, its capacity to repair and maintain tissue diminishes across every organ system. HBOT partially reverses this.
Hallmark 6: Deregulated Vasculature
Impaired vascular homeostasis and angiogenesis, one of the hallmarks of ageing, leads to reduced capillary density throughout the body, which in turn contributes to fading physical functions in the elderly.
HBOT stimulates angiogenesis - the formation of new blood vessels - through VEGF upregulation and HIF-1α activation. This restores capillary density in tissues that have progressively lost vascular supply with age, including the brain, skin, and muscle. The effects on cerebral blood flow are directly measurable on MRI and correlate with cognitive improvement - as documented in the Israeli randomised controlled trial of healthy adults over 64. See our post on HBOT and Brain Health.
The Skin Evidence: The Most Visible Proof
One of the most striking HBOT and ageing studies is one that attracted relatively little attention - perhaps because the result was too specific to generate the same headlines as telomere data.
A prospective clinical trial examining HBOT's effect on skin ageing in healthy adults over 64 performed actual skin biopsies before and after treatment. The results were objectively measured through histological analysis:
Following HBOT, there was a significant increase in collagen density (p<0.001, effect size=1.10), elastic fiber length (p<0.0001, effect size=2.71) and the number of blood vessels (p=0.02, effect size=1.00). There was a significant decrease in fiber fragmentation (p=0.012) and in tissue senescent cells (p=0.03, effect size=0.84) post-HBOT.
The study indicates, for the first time in humans, that HBOT can significantly modulate the pathophysiology of skin ageing in a healthy ageing population. The demonstrated mechanisms include angiogenesis and senescent cell clearance.
Effect sizes of 1.10 and 2.71 are, in statistical terms, very large. These are not marginal improvements measured at the limits of detection - they are substantial, histologically confirmed changes in the physical structure of ageing skin tissue. Increased collagen density, longer elastic fibres, more blood vessels, less senescent cell burden.
For context: collagen supplements - one of the biggest categories in the anti-ageing market - show improvements in skin hydration and elasticity in trials, but typically with more modest effect sizes and without the direct tissue-level evidence that biopsy provides. HBOT achieves skin collagen changes at the structural level through angiogenesis and senescent cell clearance - building the conditions in which the tissue itself regenerates, rather than adding collagen from outside.
How HBOT Compares to Other Longevity Approaches
The longevity pharmacology space is advancing rapidly, rapamycin, metformin, senolytics, NAD+ precursors, and GLP-1 agonists are all being studied and used off-label. Where does HBOT sit in this landscape?
HBOT vs. Rapamycin:
The most discussed longevity drug currently available. Topical rapamycin showed reduced skin senescence markers and improved collagen VII in a placebo-controlled trial. The PEARL trial assessed 48 weeks of intermittent low-dose rapamycin in healthy adults aged 50–85. Both show promise. But rapamycin carries meaningful immunosuppression risks, requires medical supervision for off-label longevity use, and its human evidence for systemic longevity benefits (as opposed to mouse lifespan data) is still limited. HBOT has a favourable safety profile, no immunosuppression risk, and more direct human evidence for the cellular hallmarks of ageing.
HBOT vs. Senolytics (dasatinib + quercetin):
The pharmacological approach to clearing senescent cells. Evidence is growing, but human trial data is at an earlier stage than HBOT's. HBOT achieves the same senolytic endpoint non-pharmacologically.
HBOT vs. Exercise:
Exercise is the gold standard for healthspan - it activates PGC-1α, promotes mitochondrial biogenesis, reduces inflammation, and supports cardiovascular health. HBOT activates many of the same pathways through a complementary mechanism. They are not competitors - they are synergistic. HBOT can help older adults or those with physical limitations access mitochondrial and regenerative benefits that exercise intensity might otherwise be required to achieve.
HBOT vs. NAD+ precursors (NMN, NR):
Widely used, mechanistically plausible, but human evidence for ageing-specific outcomes is still developing. HBOT's human evidence for telomere length, senescent cell clearance, and cerebral blood flow is currently stronger.
The honest summary: HBOT has more direct, peer-reviewed human evidence for reversing specific cellular hallmarks of ageing than most of the interventions that attract significantly more attention and marketing spend.
What to Expect: HBOT for Healthy Ageing at OxyPlus Newcastle
At OxyPlus, Newcastle's specialist HBOT clinic, we work with clients who want to take a proactive, evidence-based approach to their biological age. Here is what that looks like in practice:
Initial Consultation - We discuss your health history, current biomarkers where available, lifestyle factors, and longevity goals. If you have had recent blood tests including inflammatory markers, lipid panels, or biological age tests, these are useful context.
Personalised Protocol - For anti-ageing and longevity goals, the research protocols cluster around 10–40 sessions. We discuss the approach, timing, and how to integrate HBOT with other health behaviours you already practise.
Medical-Grade Sessions - 90 minutes in our clinical hyperbaric chamber at 2.4 ATA with 100% oxygen - the same parameters used in the published trials. Not a home soft chamber. Not diluted protocols.
Ongoing Review — We track your subjective and, where possible, objective markers across the course.
We are based in Newcastle and serve clients from across the North East - including Gateshead, Sunderland, Durham, Northumberland, and Teesside.
Frequently Asked Questions
-
A: The evidence is specific and peer-reviewed. Published human trials have documented: over 20% increase in telomere length, 10–37% reduction in senescent cell concentrations, significant increases in skin collagen density and elastic fibre length confirmed by biopsy, measurable cerebral blood flow improvements on MRI, and elimination of systemic inflammation in documented cases. These are not animal studies or theoretical effects - they are measured in human subjects.
-
A: Most longevity supplements have mechanistic plausibility and some supportive evidence, but relatively few have the direct human trial evidence for telomere elongation, senescent cell clearance, and skin tissue remodelling that HBOT does. HBOT and targeted supplements are not mutually exclusive - they can be complementary within a broader strategy.
-
A: The landmark telomere trial and Bryan Johnson's experiment used 60 sessions. Anti-inflammatory benefits begin within the first 10–20 sessions. Stem cell mobilisation (8× increase in circulating stem cell markers) is documented at 20 sessions. The fuller cellular ageing hallmark effects - telomere elongation, maximum senescent cell clearance - develop across longer courses. At OxyPlus Newcastle, we design protocols based on your individual goals and circumstances.
-
A: OxyPlus is Newcastle's specialist HBOT clinic, offering medical-grade hyperbaric oxygen therapy at the clinical parameters used in the published research. We serve clients across Newcastle, Gateshead, Sunderland, Durham, Northumberland, and Teesside. Visit oxyplus.co.uk to book your initial consultation.
The Verdict
The anti-ageing space is full of things that are expensive, popular, and weakly evidenced. HBOT is the opposite: accessible at clinical grade, relatively unknown outside biohacking circles, and supported by human trial data for multiple cellular hallmarks of ageing that few other interventions can match.
Whether it is the most underrated anti-ageing tool is, of course, a matter of framing. But the question is worth taking seriously. When a published 2025 paper in a peer-reviewed journal argues that HBOT remains underrepresented in longevity medicine discourse despite its evidence base, and when a systematic longevity experimenter with unlimited resources singles it out as one of the highest-value interventions he has done — that is worth paying attention to.
At OxyPlus - Newcastle's specialist HBOT clinic - the same clinical-grade protocol is available now.
👉 Book your consultation at HERE📍 OxyPlus Hyperbaric Oxygen Therapy Clinic, Newcastle upon Tyne